+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years +
All Genders
ID06038578

Randomized Study of TRK-950 With Ramucirumab and Paclitaxel Versus Ramucirumab and Paclitaxel Alone in Gastric Cancer

Led by Toray Industries, Inc · Updated on 2026-10-08

146

Participants Needed

27

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the combination of TRK-950 with ramucirumab and paclitaxel compared to ramucirumab and paclitaxel alone in people with gastric or gastro-esophageal junction adenocarcinoma. The study aims to assess the effectiveness, safety, best dose, and development of anti-drug and neutralizing antibodies of TRK-950. This is a phase 2 randomized trial focused on progression-free survival as the main outcome, along with other measures like overall survival and response rates. Participants are assigned to one of three groups one receiving 5 mgkg TRK-950 plus ramucirumab and paclitaxel, another receiving 10 mgkg TRK-950 plus the same drugs, and a third group receiving ramucirumab and paclitaxel alone. Treatments are given intravenously following a 28-day cycle schedule, with specific dosing days for each drug. The study compares these groups to find the optimal dose and monitor drug interactions and immune responses. During the trial, participants will have regular assessments including scans, clinical evaluations, and laboratory tests to monitor disease progression and side effects. Researchers will track pharmacokinetics, antibody development, and quality of life using questionnaires throughout the study, which may last up to about 24 months. Safety monitoring will continue for 45 days after the last study dose, ensuring close follow-up for any adverse events or treatment effects.

CONDITIONS

Brief Title

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Research Team

(

(Asia sites)Toray Contact for Clinical Trial Information

(

(US sites) Contact for Clinical Trial Information

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here